BOTHELL, Wash., June 25 /PRNewswire/ -- Verathon Inc., maker of BladderScan(R) bladder volume instruments and GlideScope(R) video laryngoscopes, announced today the appointment of Kendall Stever as Chief Financial Officer ("CFO"). Mr. Stever's responsibilities will include management and oversight of the Company's global financial affairs, including day to day financial functions for company headquarters in Washington State, taxation, investor relations as well as other company-wide financial functions. Mr. Stever will report directly to Verathon President and Chief Executive Officer Gerald McMorrow.
Mr. Stever replaces Maureen Graham, who is retiring from Verathon after 11 years of distinguished service. Gerald McMorrow said, "I would like to thank Maureen for her outstanding commitment to Verathon's growth and development. Maureen played a key role in the company's transition from a small, entrepreneurial start-up to the global medical device manufacturer the company is today." Ms. Graham has agreed to stay on for a period of time to assist with the transition and be a key resource on other strategic initiatives.
McMorrow stated, "I am very pleased to welcome Kendall as Verathon's incoming CFO. He is a seasoned financial executive with an outstanding track record in the medical industry. His expertise, experience and energy will be a great asset to Verathon as we continue to expand our business into both new geographies and new categories of medical devices."
Mr. Stever held various financial management positions at Immunex from 1990 to 2003, when the company was sold to Amgen for $16 billion. As Immunex's Corporate Controller he oversaw all aspects of the Company's accounting organization and played key roles in the company's various strategic activities. Prior to joining Verathon, Mr. Stever headed his own consulting business, Double Diamond Consulting LLC. Mr. Stever holds a Bachelor of Science degree in Business Administration from the University of Washington.
About Verathon Inc.
Verathon designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for noninvasive bladder volume measurement. The brand is found in over 80 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(R) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) Video Laryngoscope (GVL(R)) brand. Verathon(R) is headquartered in Bothell, Washington and has over 400 employees worldwide. For more information, please visit www.verathon.com.
Media Contact: Jane Mueller, VP of Marketing, Verathon Medical, 425.867.1348, Ext. 5600. Alternate Contacts: Nansea Carmichael, Executive Assistant - Marketing, 425.867.1348, Ext. 5607; and Jessica McNerney, Executive Assistant, 425.867.1348 Ext. 5554
BladderScan, GlideScope, GVL and Verathon are trademarks of Verathon Inc.
2009 Verathon Inc.
SOURCE Verathon Inc.